Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Yamada

Showing results (71-80 of 179) with videos related to

Pageof 18
Sort By:
Cancer Science|February 24, 2010
Analysis of inhibition of topoisomerase IIalpha and cancer cell proliferation by ingenolEZChisato Yoshida, Kazsuyoshi Hishiyama, Khosuke Miyazaki, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2019
Immune-related adverse events predict the therapeutic efficacy of pembrolizumab in urothelial cancer patientsTaketo Kawai, Yusuke Sato, Katsuhiro Makino, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 30, 2015
Nocturia in men is a chaotic condition dominated by nocturnal polyuriaTetsuya Fujimura, Yuta Yamada, Toru Sugihara, et al.
Scientific Reports|December 27, 2024
Androgen receptor and osteoglycin gene expression predicting prognosis of metastatic prostate cancerTomohiro Kameda, Toru Sugihara, Daisuke Obinata, et al.
Surgery Today|June 16, 2024
Abdominal aortic calcification volume as a preoperative prognostic predictor for pancreatic cancerYuta Yamada, Kenei Furukawa, Koichiro Haruki, et al.
Cancer Science|December 29, 2019
TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinomaYuta Yamada, Naoki Kimura, Ken-Ichi Takayama, et al.
BMC Cancer|November 4, 2015
Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trialTetsuya Fujimura, Satoru Takahashi, Haruki Kume, et al.
Urologia Internationalis|March 15, 2022
Cumulative Incidence and Clinical Risk Factors of Radiation Cystitis after Radiotherapy for Prostate CancerKatsuhiro Makino, Yusuke Sato, Ryosuke Takenaka, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 22, 2023
[AUTOTRANSPLANTATION FOR IATROGENIC URETERAL INJURY FOLLOWING GYNECOLOGICAL SURGERY]Akane Kinoshita, Daisuke Yamada, Kazuki Honda, et al.
European Urology Open Science|October 12, 2023
Efficacy and Safety of Low-dose Oral Prednisolone for Patients with Refractory Hunner-type Interstitial CystitisYoshiyuki Akiyama, Aya Niimi, Akira Nomiya, et al.
Pageof 18

Showing results (71-80 of 179) with videos related to

Sort By:
Pageof 18
Cancer Science|February 24, 2010
Analysis of inhibition of topoisomerase IIalpha and cancer cell proliferation by ingenolEZChisato Yoshida, Kazsuyoshi Hishiyama, Khosuke Miyazaki, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2019
Immune-related adverse events predict the therapeutic efficacy of pembrolizumab in urothelial cancer patientsTaketo Kawai, Yusuke Sato, Katsuhiro Makino, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 30, 2015
Nocturia in men is a chaotic condition dominated by nocturnal polyuriaTetsuya Fujimura, Yuta Yamada, Toru Sugihara, et al.
Scientific Reports|December 27, 2024
Androgen receptor and osteoglycin gene expression predicting prognosis of metastatic prostate cancerTomohiro Kameda, Toru Sugihara, Daisuke Obinata, et al.
Surgery Today|June 16, 2024
Abdominal aortic calcification volume as a preoperative prognostic predictor for pancreatic cancerYuta Yamada, Kenei Furukawa, Koichiro Haruki, et al.
Cancer Science|December 29, 2019
TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinomaYuta Yamada, Naoki Kimura, Ken-Ichi Takayama, et al.
BMC Cancer|November 4, 2015
Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trialTetsuya Fujimura, Satoru Takahashi, Haruki Kume, et al.
Urologia Internationalis|March 15, 2022
Cumulative Incidence and Clinical Risk Factors of Radiation Cystitis after Radiotherapy for Prostate CancerKatsuhiro Makino, Yusuke Sato, Ryosuke Takenaka, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 22, 2023
[AUTOTRANSPLANTATION FOR IATROGENIC URETERAL INJURY FOLLOWING GYNECOLOGICAL SURGERY]Akane Kinoshita, Daisuke Yamada, Kazuki Honda, et al.
European Urology Open Science|October 12, 2023
Efficacy and Safety of Low-dose Oral Prednisolone for Patients with Refractory Hunner-type Interstitial CystitisYoshiyuki Akiyama, Aya Niimi, Akira Nomiya, et al.
Pageof 18